ClariVest Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

ClariVest Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-42,045	Closed	-$2.45M	–	788
2019 Q2	$2.45M	Sell	42,045 -600	-1%	-$35.5K	0.06%	228
2019 Q1	$2.99M	Sell	42,645 -2,027	-5%	-$150K	0.06%	255
2018 Q4	$2.88M	Buy	44,672 +30,724	+220%	+$2.15M	0.06%	245
2018 Q3	$978K	Buy	+13,948	New	+$816K	0.02%	428

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

ClariVest Asset Management's GHDX Position: Q3 2019 in Review

ClariVest Asset Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 42,045 shares — an estimated $2.45M sold.

ClariVest Asset Management first reported a position in GHDX in Q3 2018 and held it in 4 quarters. The position peaked at $2.99M in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

ClariVest Asset Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
ClariVest Asset Management sold 42,045 Genomic Health, Inc. shares in Q3 2019, an estimated $2.45M.
ClariVest Asset Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 4 quarters.
ClariVest Asset Management's Genomic Health, Inc. position peaked at $2.99M in Q1 2019.
221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on ClariVest Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.